Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06784479Phase 4Active Not Recruiting

Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy

Role: lead

NCT06128681Recruiting

Diagnosis and Comprehensive Treatment of Mediastinal Interventional Technique

Role: lead

NCT05838183Recruiting

Interstitial Lung Disease and Obstructive Sleep Apnea

Role: lead

All 3 trials loaded